Tobacco use is a global health problem with 1.13 billion smokers and 8 million deaths annually, including 1.2 million from second-hand smoke. With a smoking prevalence of 27.2%, India is the thirty-seventh country with the highest smoking prevalence. It is a burden on individuals, communities and economies, causing various diseases and preventable deaths. Tobacco is a major risk factor for non-communicable diseases such as chronic respiratory and cardiovascular diseases, cancer and diabetes.
This digital event was organised by the Indian Pharmaceutical Association (IPA) in collaboration with the International Pharmaceutical Federation (FIP) and the World Health Organisation (WHO). During the webinar, the FIP presented the two new publications on tobacco cessation: “Supporting tobacco cessation and the treatment of tobacco dependence: A handbook for pharmacists” and the “Knowledge and skills reference guide for professional development in tobacco cessation and other risk factors in NCDs”.
